Hiroshi Yoshioka

Title(s)Recall Hcomp, Radiological Sciences
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-8849
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG). Jpn J Clin Oncol. 2024 Oct 23. Sekino Y, Hishida T, Yoshioka H, Wakabayashi M, Mitome N, Shiono S, Kenmotsu H, Nosaki K, Aokage K, Horinouchi H, Fukuda H, Ohe Y, Watanabe SI, Lung Cancer Surgical Study Group (LCSSG) and the Lung Cancer Study Group (LCSG) of the Japan Clinica. PMID: 39444315.
      View in: PubMed   Mentions:    Fields:    
    2. Risk factors for locoregional relapse after segmentectomy: Supplementary analysis of the JCOG0802/WJOG4607L trial. J Thorac Oncol. 2024 Oct 10. Nakagawa K, Watanabe SI, Wakabayashi M, Yotsukura M, Mimae T, Hattori A, Miyoshi T, Isaka M, Endo M, Yoshioka H, Tsutani Y, Isaka T, Maniwa T, Nakajima R, Suzuki K, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Sekino Y, Nakamura K, Fukuda H. PMID: 39395662.
      View in: PubMed   Mentions:    Fields:    
    3. High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group). Jpn J Clin Oncol. 2024 Oct 03; 54(10):1084-1092. Watanabe K, Sasaki K, Machida R, Shimizu J, Yamane Y, Tamiya M, Saito S, Takada Y, Yoh K, Yoshioka H, Murakami H, Kitazono S, Goto Y, Horinouchi H, Ohe Y. PMID: 39158350.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clin Lung Cancer. 2024 Oct 01. Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. PMID: 39482146.
      View in: PubMed   Mentions:    Fields:    
    5. [More Personalized Treatment using Diversified Molecular Targeted Therapy Strategies for EGFR Mutation-Positive Non-Small-Cell Lung Cancer-Sequential Treatment Comprising First- and Second-Line Therapy with EGFR-TKIs and Treatment Options in Combination with Anti-Angiogenic Agents]. Gan To Kagaku Ryoho. 2024 Oct; 51(10):1003-1011. Seki N, Yoshioka H, Wakabayashi S, Enatsu S. PMID: 39571983.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer. Cancers (Basel). 2024 Sep 11; 16(18). Yamanaka Y, Ota T, Masuoka Y, Takeyasu Y, Nakamura S, Terashima M, Yoshioka H, Fukuoka M, Kurata T. PMID: 39335099; PMCID: PMC11430718.
      View in: PubMed   Mentions:
    7. Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future. Jpn J Clin Oncol. 2024 Aug 20. Watanabe SI, Yotsukura M, Miyoshi T, Hattori A, Isaka T, Maniwa T, Isaka M, Yoshioka H, Endo M, Mimae T, Tsutani Y, Nakagawa K, Aokage K, Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). PMID: 39163130.
      View in: PubMed   Mentions:    Fields:    
    8. The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase. Jpn J Clin Oncol. 2024 Aug 19. Nakagawa K, Yotsukura M, Mimae T, Hattori A, Miyoshi T, Isaka M, Endo M, Tsutani Y, Isaka T, Maniwa T, Nakajima R, Yoshioka H, Takei H, Aokage K, Watanabe SI. PMID: 39158320.
      View in: PubMed   Mentions:    Fields:    
    9. Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047). Lung Cancer. 2024 Aug; 194:107894. Asao T, Shukuya T, Uemura K, Kitadai R, Yamamoto G, Mouri A, Tamaoka M, Imai R, Tsukita Y, Isobe K, Watanabe S, Kamimura M, Morita R, Kudo K, Inomata M, Tateishi K, Kakinuma K, Yoshioka H, Namba Y, Sumiyoshi I, Nakagawa T, Watanabe K, Kobayashi K, Takahashi K. PMID: 39029359.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC. N Engl J Med. 2024 Jun 26. Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Yang JC, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Sendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Passaro A, Kim SW, Gadgeel SM, Xie J, Sun T, Martinez M, Ennis M, Fennema E, Daksh M, Millington D, Leconte I, Iwasawa R, Lorenzini P, Baig M, Shah S, Bauml JM, Shreeve SM, Sethi S, Knoblauch RE, Hayashi H, MARIPOSA Investigators. PMID: 38924756.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    11. Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer. Jpn J Clin Oncol. 2024 Mar 09; 54(3):305-311. Katsushima U, Hase K, Fukushima T, Kubo T, Nakano J, Ogushi N, Okuno Y, Kamisako K, Nakanishi K, Okazaki Y, Ikoma T, Takeyasu Y, Yamanaka Y, Yoshioka H, Imai Y, Kurata T. PMID: 38213068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas. Clin Lung Cancer. 2024 Jun; 25(4):389-394. Okuma Y, Nomura S, Sakakibara-Konishi J, Tsukita Y, Murakami S, Hosomi Y, Tambo Y, Kogure Y, Yoshioka H, Tamiya M, Ninomiya K, Iwama E. PMID: 38413246.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    13. Rare but clinically important salivary gland-type tumor of the lung: A review. Jpn J Clin Oncol. 2024 Feb 07; 54(2):121-128. Takamori S, Yatabe Y, Osoegawa A, Aokage K, Yoshioka H, Miyoshi T, Mimae T, Endo M, Hattori A, Yotsukura M, Isaka T, Isaka M, Maniwa T, Nakajima R, Watanabe SI. PMID: 37952098.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer. Eur J Cardiothorac Surg. 2023 Dec 01; 64(6). Miyoshi T, Ito H, Wakabayashi M, Hashimoto T, Sekino Y, Suzuki K, Tsuboi M, Moriya Y, Yoshino I, Isaka T, Hattori A, Mimae T, Isaka M, Maniwa T, Endo M, Yoshioka H, Nakagawa K, Nakajima R, Tsutani Y, Saji H, Okada M, Aokage K, Fukuda H, Watanabe SI. PMID: 37930048.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study). Thorac Cancer. 2024 Jan; 15(2):163-171. Yamaguchi O, Mori K, Takata S, Shibata K, Chikamori K, Kimura N, Nagai Y, Nakagawa T, Igawa S, Harada T, Yoshioka H, Tanaka H, Nogawa H, Satoh H, Shiozawa T, Tsuji K, Kobayashi K, Kaira K. PMID: 38013668; PMCID: PMC10788474.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma. JTO Clin Res Rep. 2024 Jan; 5(1):100613. Hazama D, Nakahama K, Kodama H, Miyazaki A, Azuma K, Kawashima Y, Sato Y, Ito K, Shiraishi Y, Miura K, Takahama T, Oizumi S, Namba Y, Ikeda S, Yoshioka H, Tsuya A, Yasuda Y, Negi Y, Hara A, Toda M, Tachihara M. PMID: 38229769; PMCID: PMC10788284.
      View in: PubMed   Mentions: 1  
    17. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L. J Thorac Cardiovasc Surg. 2024 Sep; 168(3):674-683.e1. Maniwa T, Okami J, Miyoshi T, Wakabayashi M, Yoshioka H, Mimae T, Endo M, Hattori A, Nakagawa K, Isaka T, Isaka M, Kita R, Sekino Y, Mitome N, Aokage K, Saji H, Nakajima R, Okada M, Tsuboi M, Asamura H, Fukuda H, Watanabe SI, West Japan Oncology Group and Japan Clinical Oncology Group. PMID: 38000629.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. J Clin Oncol. 2024 Jan 10; 42(2):180-191. Garon EB, Lu S, Goto Y, De Marchi P, Paz-Ares L, Spigel DR, Thomas M, Yang JC, Ardizzoni A, Barlesi F, Orlov S, Yoshioka H, Mountzios G, Khanna S, Bossen C, Carbini M, Turri S, Myers A, Cho BC. PMID: 37788412.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    19. Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR+non-small-cell lung cancer. Transl Lung Cancer Res. 2023 Jun 30; 12(6):1167-1184. Nishio M, Atagi S, Goto K, Hosomi Y, Seto T, Hida T, Nakagawa K, Yoshioka H, Nogami N, Maemondo M, Nagase S, Okamoto I, Yamamoto N, Igawa Y, Tajima K, Fukuoka M, Yamamoto N, Nishio K. PMID: 37425411; PMCID: PMC10326775.
      View in: PubMed   Mentions: 2  
    20. Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201. PLoS One. 2023; 18(5):e0285273. Yamamoto H, Soh J, Okumura N, Suzuki H, Nakata M, Fujiwara T, Gemba K, Sano I, Fujinaga T, Kataoka M, Terazaki Y, Fujimoto N, Kataoka K, Kosaka S, Yamashita M, Inokawa H, Inoue M, Nakamura H, Yamashita Y, Hotta K, Yoshioka H, Morita S, Matsuo K, Sakamoto J, Date H, Toyooka S. PMID: 37205678; PMCID: PMC10198543.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    21. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial. Lancet Respir Med. 2023 06; 11(6):540-549. Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI, Japan Clinical Oncology Group. PMID: 36893780.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    22. Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial. BMC Cancer. 2023 Jan 03; 23(1):6. Miura S, Koh Y, Azuma K, Yoshioka H, Koyama K, Teraoka S, Ishii H, Kibata K, Ozawa Y, Tokito T, Oyanagi J, Shimokawa T, Kurata T, Yamamoto N, Tanaka H. PMID: 36597021; PMCID: PMC9808978.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    23. Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment. Clin Lung Cancer. 2022 11; 23(7):585-592. Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. PMID: 36114096.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    24. Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405). Int J Clin Oncol. 2022 Sep; 27(9):1404-1412. Haratake N, Shimokawa M, Seto T, Yoshioka H, Yamamoto N, Nakagawa K, Mitsudomi T. PMID: 35723758.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    25. Improved Productivity Using Deep Learning-assisted Reporting for Lumbar Spine MRI. Radiology. 2022 10; 305(1):160-166. Lim DSW, Makmur A, Zhu L, Zhang W, Cheng AJL, Sia DSY, Eide SE, Ong HY, Jagmohan P, Tan WC, Khoo VM, Wong YM, Thian YL, Baskar S, Teo EC, Algazwi DAR, Yap QV, Chan YH, Tan JH, Kumar N, Ooi BC, Yoshioka H, Quek ST, Hallinan JTPD. PMID: 35699577.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    26. A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non-small cell lung cancer harboring EGFR mutations (JMTO LC12-01). Thorac Cancer. 2022 06; 13(12):1827-1836. Asami K, Ando M, Nishimura T, Yokoi T, Tamura A, Minato K, Mori M, Ogushi F, Yamamoto A, Yoshioka H, Kawahara M, Atagi S. PMID: 35562327; PMCID: PMC9200881.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    27. Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B). Int J Clin Oncol. 2022 Apr; 27(4):823-824. Tsubata Y, Watanabe K, Saito R, Nakamura A, Yoshioka H, Morita M, Honda R, Kanaji N, Oizumi S, Jingu D, Nakagawa T, Nakazawa K, Mouri A, Takeuchi S, Furuya N, Akazawa Y, Miura K, Ichihara E, Maemondo M, Morita S, Kobayashi K, Isobe T. PMID: 35257278; PMCID: PMC9172770.
      View in: PubMed   Mentions:    Fields:    
    28. Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer. BMC Cancer. 2022 Feb 08; 22(1):154. Kaneda T, Kurata T, Yoshida T, Kibata K, Yoshioka H, Yanagimoto H, Takeda K, Yoshida T, Tsuta K. PMID: 35135489; PMCID: PMC8822674.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study). J Immunother Cancer. 2022 02; 10(2). Seto T, Nosaki K, Shimokawa M, Toyozawa R, Sugawara S, Hayashi H, Murakami H, Kato T, Niho S, Saka H, Oki M, Yoshioka H, Okamoto I, Daga H, Azuma K, Tanaka H, Nishino K, Tohnai R, Yamamoto N, Nakagawa K. PMID: 35105689; PMCID: PMC8808447.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    30. Measurement of Medial Tibial Eminence Dimensions for the Clinical Evaluation of ACL-Injured Knees: A Comparison between CT and MRI. J Knee Surg. 2023 May; 36(6):667-672. Stepanyan H, Nazaroff J, Le N, Parker R, Tando T, Yoshioka H, Wang D. PMID: 34952550.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L. Cancer Sci. 2022 Jan; 113(1):221-228. Sakata S, Otsubo K, Yoshida H, Ito K, Nakamura A, Teraoka S, Matsumoto N, Shiraishi Y, Haratani K, Tamiya M, Ikeda S, Miura S, Tanizaki J, Omori S, Yoshioka H, Hata A, Yamamoto N, Nakagawa K. PMID: 34704312; PMCID: PMC8748216.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    32. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT). J Clin Oncol. 2022 01 20; 40(3):231-241. Tada H, Mitsudomi T, Misumi T, Sugio K, Tsuboi M, Okamoto I, Iwamoto Y, Sakakura N, Sugawara S, Atagi S, Takahashi T, Hayashi H, Okada M, Inokawa H, Yoshioka H, Takahashi K, Higashiyama M, Yoshino I, Nakagawa K, West Japan Oncology Group. PMID: 34726958.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    33. Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non-Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L). Clin Lung Cancer. 2022 05; 23(3):e257-e263. Haratake N, Hayashi H, Shimokawa M, Nakano Y, Azuma K, Oki M, Ota K, Yoshioka H, Sakamoto T, Yamamoto N, Nakagawa K, Seto T. PMID: 34887192.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    34. Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B). Int J Clin Oncol. 2022 Jan; 27(1):112-120. Tsubata Y, Watanabe K, Saito R, Nakamura A, Yoshioka H, Morita M, Honda R, Kanaji N, Ohizumi S, Jingu D, Nakagawa T, Nakazawa K, Mouri A, Takeuchi S, Furuya N, Akazawa Y, Miura K, Ichihara E, Maemondo M, Morita S, Kobayashi K, Isobe T. PMID: 34643820; PMCID: PMC8732858.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    35. Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer. Invest New Drugs. 2022 02; 40(1):106-114. Omori S, Harada H, Mori K, Hisamatsu Y, Tsuboguchi Y, Yoshioka H, Morinaga R, Daga H, Kurata T, Takahashi T. PMID: 34495421.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    36. Review of Quantitative Knee Articular Cartilage MR Imaging. Magn Reson Med Sci. 2022 Mar 01; 21(1):29-40. Banjar M, Horiuchi S, Gedeon DN, Yoshioka H. PMID: 34471014; PMCID: PMC9199985.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    37. Interpretable and Lightweight 3-D Deep Learning Model for Automated ACL Diagnosis. IEEE J Biomed Health Inform. 2021 07; 25(7):2388-2397. Jeon Y, Yoshino K, Hagiwara S, Watanabe A, Quek ST, Yoshioka H, Feng M. PMID: 34003757.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR). Transl Lung Cancer Res. 2021 Jul; 10(7):3059-3070. Udagawa H, Sugiyama E, Harada T, Atagi S, Koyama R, Watanabe S, Nakamura Y, Harada D, Hataji O, Tanaka F, Kida H, Satouchi M, Maeno K, Inoue A, Yoh K, Yamane Y, Urata Y, Yoshioka H, Yamanaka T, Goto K. PMID: 34430347; PMCID: PMC8350093.
      View in: PubMed   Mentions: 2  
    39. Deep Learning Model for Automated Detection and Classification of Central Canal, Lateral Recess, and Neural Foraminal Stenosis at Lumbar Spine MRI. Radiology. 2021 07; 300(1):130-138. Hallinan JTPD, Zhu L, Yang K, Makmur A, Algazwi DAR, Thian YL, Lau S, Choo YS, Eide SE, Yap QV, Chan YH, Tan JH, Kumar N, Ooi BC, Yoshioka H, Quek ST. PMID: 33973835.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    40. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301. BMC Cancer. 2021 May 06; 21(1):506. Okumura N, Soh J, Suzuki H, Nakata M, Fujiwara T, Nakamura H, Sonobe M, Fujinaga T, Kataoka K, Gemba K, Kataoka M, Hotta K, Yoshioka H, Matsuo K, Sakamoto J, Date H, Toyooka S. PMID: 33957881; PMCID: PMC8101150.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    41. Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A). Jpn J Clin Oncol. 2021 Apr 30; 51(5):685-692. Katayama H, Mizusawa J, Fukuda H, Nakamura S, Nakamura K, Saijo N, Yokoyama A, Ohe Y, Shinkai T, Nakagawa K, Abe T, Mitsuoka S, Okamoto H, Yamamoto N, Yoshioka H, Ando M, Tamura T, Takeda K. PMID: 33479759.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    42. Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC. J Thorac Oncol. 2021 09; 16(9):1523-1532. Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. PMID: 33915251.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    43. Pembrolizumab plus chemotherapy-induced pneumonitis in chemo-naïve patients with non-squamous non-small cell lung cancer: A multicentre, retrospective cohort study. Eur J Cancer. 2021 06; 150:63-72. Fujimoto D, Miura S, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Yokoi T, Asao T, Tamiya M, Nakamura A, Yoshioka H, Haratani K, Teraoka S, Tokito T, Murakami S, Tamiya A, Itoh S, Yokouchi H, Watanabe S, Yamaguchi O, Tomii K, Yamamoto N. PMID: 33892408.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    44. Quantitative MRI Analysis of the Talocrural and Talonavicular Joints in Ballet Dancers. J Dance Med Sci. 2021 Mar 15; 25(1):38-45. Tando T, Horiuchi S, Yu HJ, Luk A, Russell JA, Sharp K, Yoshioka H. PMID: 33706854.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Enhanced expression of hyaluronic acid in osteoarthritis-affected knee-cartilage chondrocytes during three-dimensional in vitro culture in a hyaluronic-acid-retaining polymer scaffold. Knee. 2021 Mar; 29:365-373. Katoh S, Yoshioka H, Senthilkumar R, Preethy S, Abraham SJK. PMID: 33690017.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    46. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer. Jpn J Clin Oncol. 2021 Mar 03; 51(3):333-344. Yamaguchi M, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Shiono S, Yoshioka H, Aoki T, Tsutani Y, Okada M, Watanabe SI, Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). PMID: 33506253.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    47. A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401. Support Care Cancer. 2021 Sep; 29(9):5237-5244. Ninomiya K, Yokoyama T, Hotta K, Oze I, Katsui K, Hata T, Yoshioka H, Bessho A, Hosokawa S, Kuyama S, Kudo K, Kozuki T, Harada D, Yasugi M, Murakami T, Nakanishi M, Takigawa N, Maeda Y, Kiura K, Okayama Lung Cancer Study Group. PMID: 33649919.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Crizotinib for recurring non-small-cell lung cancer with EML4-ALK fusion genes previously treated with alectinib: A phase II trial. Thorac Cancer. 2021 03; 12(5):643-649. Harada D, Isozaki H, Kozuki T, Yokoyama T, Yoshioka H, Bessho A, Hosokawa S, Takata I, Takigawa N, Hotta K, Kiura K, Okayama Lung Cancer Study Group. PMID: 33470536; PMCID: PMC7919114.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    49. A three-dimensional in vitro culture environment of a novel polymer scaffold, yielding chondroprogenitors and mesenchymal stem cells in human chondrocytes derived from osteoarthritis-affected cartilage tissue. J Orthop. 2021 Jan-Feb; 23:138-141. Katoh S, Yoshioka H, Iwasaki M, Senthilkumar R, Rajmohan M, Karthick R, Preethy S, Abraham SJ. PMID: 33510554; PMCID: PMC7815488.
      View in: PubMed   Mentions: 5  
    50. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer. Jpn J Clin Oncol. 2021 Jan 01; 51(1):28-36. Yotsukura M, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Shiono S, Yoshioka H, Aoki T, Tsutani Y, Okada M, Watanabe SI, Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). PMID: 33147608.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Comparison of visibility of ulnar sided triangular fibrocartilage complex (TFCC) ligaments between isotropic three-dimensional and two-dimensional high-resolution FSE MR images. Eur J Radiol. 2021 Jan; 134:109418. Banjar M, Nor FEM, Singh P, Horiuchi S, Quek ST, Yoshioka H. PMID: 33302025.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis. Lung Cancer. 2020 12; 150:83-89. Ohashi K, Ninomiya K, Yoshioka H, Bessho A, Shibayama T, Aoe K, Ishikawa N, Kozuki T, Kawai H, Kuyama S, Miyoshi S, Fujitaka K, Obata H, Tsubata Y, Awaya Y, Inoue M, Inoue K, Horita N, Yanai H, Hotta K, Kiura K. PMID: 33096420.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer. Oncologist. 2021 01; 26(1):19-e52. Hayashi H, Ogura M, Niwa T, Yokoyama T, Tanizaki J, Ozaki T, Yoshioka H, Kurata T, Tamura Y, Fujisaka Y, Tanaka K, Hasegawa Y, Kudo K, Chiba Y, Nakagawa K. PMID: 32918791; PMCID: PMC7794196.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    54. A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L). Cancer. 2020 08 15; 126(16):3648-3656. Tanaka K, Morita S, Ando M, Yokoyama T, Nakamura A, Yoshioka H, Ishiguro T, Miura S, Toyozawa R, Oguri T, Daga H, Ko R, Bessho A, Tachihara M, Iwamoto Y, Hirano K, Nakanishi Y, Nakagawa K, Yamamoto N, Okamoto I. PMID: 32484914.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    55. A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer. Anticancer Res. 2020 May; 40(5):2981-2987. Yoshida H, Kim YH, Sakamori Y, Nagai H, Ozasa H, Kaneda T, Yoshioka H, Nakagawa H, Tomii K, Okada A, Yoshimura K, Hirabayashi M, Hirai T. PMID: 32366452.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    56. T1rho and T2 mapping of ankle cartilage of female and male ballet dancers. Acta Radiol. 2020 Oct; 61(10):1365-1376. Horiuchi S, Yu HJ, Luk A, Rudd A, Ton J, Kuoy E, Russell JA, Sharp K, Yoshioka H. PMID: 32028774.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Therapies after first-line afatinib in patients with EGFRm+ NSCLC in Japan: retrospective analysis of LUX-Lung 3. Future Oncol. 2020 Feb; 16(4):49-60. Yoshioka H, Kato T, Okamoto I, Tanaka H, Hida T, Seto T, Kiura K, Tian Y, Azuma H, Yamamoto N. PMID: 31922425.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    58. Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L). J Clin Oncol. 2020 03 10; 38(8):793-803. Seto T, Azuma K, Yamanaka T, Sugawara S, Yoshioka H, Wakuda K, Atagi S, Iwamoto Y, Hayashi H, Okamoto I, Saka H, Mitsuoka S, Fujimoto D, Nishino K, Horiike A, Daga H, Sone T, Yamamoto N, Nakagawa K, Nakanishi Y. PMID: 31880966.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    59. Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer. Lung Cancer. 2020 01; 139:195-199. Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim YH, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M, Hasegawa W, Tamura T. PMID: 31812890.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    60. Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L). Jpn J Clin Oncol. 2019 Oct 01; 49(10):947-955. Kimura T, Kawaguchi T, Chiba Y, Yoshioka H, Watanabe K, Kijima T, Kogure Y, Oguri T, Yoshimura N, Niwa T, Kasai T, Hayashi H, Ono A, Asai K, Tanaka H, Yano S, Yamamoto N, Nakanishi Y, Nakagawa K. PMID: 31242302.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    61. A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302. Oncology. 2019; 97(6):327-333. Ikeda S, Yoshioka H, Kaneda T, Yokoyama T, Niwa T, Sone N, Ishida T, Morita M, Tomioka H, Komaki C, Hirabayashi M, Hasegawa Y, Noguchi T, Nakano Y, Sakaguchi C, Yoshimura K, Hirai T. PMID: 31412347.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    62. A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY). Chest. 2019 08; 156(2):357-366. Ninomiya K, Hata T, Yoshioka H, Ohashi K, Bessho A, Hosokawa S, Ishikawa N, Yamasaki M, Shibayama T, Aoe K, Kozuki T, Harita S, Ueda Y, Murakami T, Fujimoto N, Yanai H, Toyooka S, Takata M, Hotta K, Kiura K, HER2-CS Network. PMID: 31072612.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    63. Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62]. Lung Cancer. 2019 Jun; 132:157-158. Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Yamamoto N, Nishio M, Ohe Y, Kato T, Takahashi T, Kamada A, Suzukawa K, Omori Y, Enatsu S, Nakagawa K, Tamura T. PMID: 31014853.
      View in: PubMed   Mentions:    Fields:    
    64. A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement. Asia Pac J Clin Oncol. 2019 Aug; 15(4):250-256. Harada D, Kozuki T, Nogami N, Bessho A, Hosokawa S, Fukamatsu N, Hotta K, Ohashi K, Kubo T, Yoshioka H, Yokoyama T, Sone N, Kuyama S, Kudo K, Yasugi M, Takigawa N, Oze I, Kiura K. PMID: 30938103; PMCID: PMC6849786.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    65. A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402). Lung Cancer. 2019 09; 135:175-180. Yokoyama T, Yoshioka H, Fujimoto D, Demura Y, Hirano K, Kawai T, Kagami R, Washio Y, Ishida T, Kogo M, Tomii K, Okuno T, Akai M, Hirabayashi M, Nishimura T, Nakahara Y, Kim YH, Miyakoshi C, Yoshimura K, Hirai T, Kyoto Thoracic Oncology Research Group (KTORG). PMID: 31446992.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    66. Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer. Anticancer Res. 2019 Mar; 39(3):1463-1468. Nakashima K, Akamatsu H, Murakami H, Niwa T, Iwamoto Y, Ozawa Y, Yokoyama T, Shoda H, Yamamoto N, Yoshioka H, Masuda K, Naito T, Mori K, Takahashi T. PMID: 30842183.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    67. KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer. Cancer Sci. 2019 Mar; 110(3):1012-1020. Nishio M, Takahashi T, Yoshioka H, Nakagawa K, Fukuhara T, Yamada K, Ichiki M, Tanaka H, Seto T, Sakai H, Kasahara K, Satouchi M, Han SR, Noguchi K, Shimamoto T, Kato T. PMID: 30618179; PMCID: PMC6398876.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    68. Non-small cell lung cancer with pathological complete response: predictive factors and surgical outcomes. Gen Thorac Cardiovasc Surg. 2019 Sep; 67(9):773-781. Kayawake H, Okumura N, Yamanashi K, Takahashi A, Itasaka S, Yoshioka H, Nakashima T, Matsuoka T. PMID: 30725275.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan. Lung Cancer. 2019 03; 129:55-62. Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Yamamoto N, Nishio M, Ohe Y, Kato T, Takahashi T, Kamada A, Suzukawa K, Omori Y, Enatsu S, Nakagawa K, Tamura T. PMID: 30797492.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    70. Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer. In Vivo. 2019 Jan-Feb; 33(1):163-166. Kitagawa C, Iwasaku M, Kogure Y, Ando M, Yoshioka H, Nishiyama A, Watanabe N, Kunimasa K, Tsubouchi K, Oka S, Saka H. PMID: 30587617; PMCID: PMC6364089.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    71. New scoring system in assessment of Hoffa's fat pad synovitis: A comparative study with established scoring systems. World J Radiol. 2018 Nov 28; 10(11):162-171. Hagiwara S, Yang A, Takao S, Kaneko Y, Nozaki T, Yoshioka H. PMID: 30568750; PMCID: PMC6288675.
      View in: PubMed   Mentions: 2  
    72. Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report. Mol Clin Oncol. 2019 Feb; 10(2):267-269. Niki M, Nakaya A, Kurata T, Nakahama K, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S. PMID: 30680206; PMCID: PMC6327220.
      View in: PubMed   Mentions: 10  
    73. Pseudoprogression in Previously Treated Patients with Non-Small Cell Lung Cancer Who Received Nivolumab Monotherapy. J Thorac Oncol. 2019 03; 14(3):468-474. Fujimoto D, Yoshioka H, Kataoka Y, Morimoto T, Hata T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T. PMID: 30468872.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    74. Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer. In Vivo. 2018 Nov-Dec; 32(6):1581-1586. Yoshioka H, Kogure Y, Ando M, Kitagawa C, Iwasaku M, Niwa T, Saka H. PMID: 30348719; PMCID: PMC6365753.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    75. Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer. Oncotarget. 2018 Aug 17; 9(64):32298-32304. Niki M, Nakaya A, Kurata T, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S. PMID: 30190787; PMCID: PMC6122346.
      View in: PubMed   Mentions: 38     Fields:    
    76. Surgical outcomes and complications of pneumonectomy after induction therapy for non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2018 Nov; 66(11):658-663. Kayawake H, Okumura N, Yamanashi K, Otsuki Y, Takahashi A, Itasaka S, Yoshioka H, Nakashima T, Matsuoka T. PMID: 30083866.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Comparison Between Isotropic 3-Dimensional Fat-Suppressed T2-Weighted Fast Spin Echo (FSE) and Conventional 2-Dimensional Fat-Suppressed Proton-Weighted FSE Shoulder Magnetic Resonance Imaging at 3-T in Patients With Shoulder Pain. J Comput Assist Tomogr. 2018 Jul/Aug; 42(4):559-565. Horiuchi S, Nozaki T, Tasaki A, Ohde S, Deshpande GA, Starkey J, Hara T, Kitamura N, Yoshioka H. PMID: 29489594.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Novel valosin-containing protein mutations associated with multisystem proteinopathy. Neuromuscul Disord. 2018 06; 28(6):491-501. Al-Tahan S, Al-Obeidi E, Yoshioka H, Lakatos A, Weiss L, Grafe M, Palmio J, Wicklund M, Harati Y, Omizo M, Udd B, Kimonis V. PMID: 29754758.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    79. Assessing patterns of T2/T1rho change in grade 1 cartilage lesions of the distal femur using an angle/layer dependent approach. Clin Imaging. 2018 Jul - Aug; 50:201-207. Kaneko Y, Nozaki T, Yu H, Schwarzkopf R, Hara T, Yoshioka H. PMID: 29660530; PMCID: PMC6015552.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    80. Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study. Lung Cancer. 2018 05; 119:14-20. Fujimoto D, Yoshioka H, Kataoka Y, Morimoto T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T. PMID: 29656747.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    81. Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab. Int J Clin Oncol. 2018 Aug; 23(4):634-640. Nakaya A, Kurata T, Yoshioka H, Takeyasu Y, Niki M, Kibata K, Satsutani N, Ogata M, Miyara T, Nomura S. PMID: 29442281; PMCID: PMC6097082.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    82. Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer. BMC Cancer. 2018 01 02; 18(1):6. Kaneda T, Yoshioka H, Tamiya M, Tamiya A, Hata A, Okada A, Niwa T, Shiroyama T, Kanazu M, Ishida T, Katakami N. PMID: 29291705; PMCID: PMC5749021.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    83. Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer. Anticancer Res. 2018 01; 38(1):559-563. Kataoka Y, Hirano K, Narabayashi T, Hara S, Fujimoto D, Tanaka T, Ebi N, Tomii K, Yoshioka H. PMID: 29277824.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    84. Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study. Cancer Chemother Pharmacol. 2018 02; 81(2):333-337. Kataoka Y, Hirano K, Narabayashi T, Hara S, Fujimoto D, Tanaka T, Ebi N, Tomii K, Yoshioka H. PMID: 29230503.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer. Jpn J Clin Oncol. 2017 Dec 01; 47(12):1112-1118. Watanabe SI, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Saji H, Yoshioka H, Zenke Y, Aoki T, Tsutani Y, Okada M, Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (J. PMID: 29136212.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    86. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status. BMC Cancer. 2017 Nov 28; 17(1):797. Ikeda S, Yoshioka H, Ikeo S, Morita M, Sone N, Niwa T, Nishiyama A, Yokoyama T, Sekine A, Ogura T, Ishida T. PMID: 29183294; PMCID: PMC5704395.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    87. Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol. 2017 Nov 10; 35(32):3662-3670. Kubota K, Yoshioka H, Oshita F, Hida T, Yoh K, Hayashi H, Kato T, Kaneda H, Yamada K, Tanaka H, Ichinose Y, Park K, Cho EK, Lee KH, Lin CB, Yang JC, Hara K, Asato T, Nakagawa K. PMID: 28902534.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    88. Advanced Imaging Techniques of the Wrist. AJR Am J Roentgenol. 2017 Sep; 209(3):497-510. Chang AL, Yu HJ, von Borstel D, Nozaki T, Horiuchi S, Terada Y, Yoshioka H. PMID: 28829171.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    89. Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas® EGFR mutation test. Lung Cancer. 2017 09; 111:190-194. Satouchi M, Tanaka H, Yoshioka H, Shimokawaji T, Mizuno K, Takeda K, Yoshino I, Seto T, Kurata T, Tashiro N, Hagiwara K. PMID: 28838392.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    90. Reliability of MR Quantification of Rotator Cuff Muscle Fatty Degeneration Using a 2-point Dixon Technique in Comparison with the Goutallier Classification: Validation Study by Multiple Readers. Acad Radiol. 2017 11; 24(11):1343-1351. Horiuchi S, Nozaki T, Tasaki A, Yamakawa A, Kaneko Y, Hara T, Yoshioka H. PMID: 28554550.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    91. A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rationale and Protocol Design for the WJOG8515L Study. Clin Lung Cancer. 2017 11; 18(6):719-723. Hayashi H, Chiba Y, Sakai K, Fujita T, Yoshioka H, Sakai D, Kitagawa C, Naito T, Takeda K, Okamoto I, Mitsudomi T, Kawakami Y, Nishio K, Nakamura S, Yamamoto N, Nakagawa K. PMID: 28623122.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    92. T1rho and T2 relaxation times of the normal adult knee meniscus at 3T: analysis of zonal differences. BMC Musculoskelet Disord. 2017 05 18; 18(1):202. Takao S, Nguyen TB, Yu HJ, Hagiwara S, Kaneko Y, Nozaki T, Iwamoto S, Otomo M, Schwarzkopf R, Yoshioka H. PMID: 28521823; PMCID: PMC5437607.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    93. High-resolution 3 T MRI of traumatic and degenerative triangular fibrocartilage complex (TFCC) abnormalities using Palmer and Outerbridge classifications. Clin Radiol. 2017 Oct; 72(10):904.e1-904.e10. Nozaki T, Rafijah G, Yang L, Ueno T, Horiuchi S, Hitt D, Yoshioka H. PMID: 28522258.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Lancet. 2017 07 01; 390(10089):29-39. Hida T, Nokihara H, Kondo M, Kim YH, Azuma K, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Imamura F, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Shukuya T, Nakagawa K, Mitsudomi T, Yamamoto N, Asakawa T, Asabe R, Tanaka T, Tamura T. PMID: 28501140.
      View in: PubMed   Mentions: 430     Fields:    Translation:HumansCTClinical Trials
    95. T1ρ/T2 mapping and histopathology of degenerative cartilage in advanced knee osteoarthritis. World J Orthop. 2017 Apr 18; 8(4):350-356. Kester BS, Carpenter PM, Yu HJ, Nozaki T, Kaneko Y, Yoshioka H, Schwarzkopf R. PMID: 28473964; PMCID: PMC5396021.
      View in: PubMed   Mentions: 7  
    96. A statistical issue regarding the original paper by M. Tamiya and others (Med Oncol (2016) 33:2 DOI 10.1007/s12032-015-0715-7). Med Oncol. 2017 05; 34(5):80. Yoshioka H, Kaneda T, Yokoyama T. PMID: 28386835.
      View in: PubMed   Mentions:    Fields:    
    97. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017 05; 18(5):663-671. Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, Takeda K, Yoshioka H, Tachihara M, Sakai H, Goto K, Yamamoto N. PMID: 28343976.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansCTClinical Trials
    98. Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP. J Clin Oncol. 2017 May 10; 35(14):1515-1521. Tamura T, Kiura K, Seto T, Nakagawa K, Maemondo M, Inoue A, Hida T, Yoshioka H, Harada M, Ohe Y, Nogami N, Murakami H, Kuriki H, Shimada T, Tanaka T, Takeuchi K, Nishio M. PMID: 28296581; PMCID: PMC5455704.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    99. High-resolution MRI of the ulnar and radial collateral ligaments of the wrist. Acta Radiol. 2017 Dec; 58(12):1493-1499. Nozaki T, Wu W, Kaneko Y, Rafijah G, Yang L, Hitt D, Yoshioka H. PMID: 28292199.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    100. Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003). Cancer Chemother Pharmacol. 2017 04; 79(4):689-695. Hata A, Katakami N, Hattori Y, Tanaka K, Fujita S, Kotani Y, Nishimura T, Imamura F, Yokota S, Satouchi M, Monden K, Otsuka K, Nishiyama A, Tsubouchi K, Kaneda T, Yoshioka H, Morita S, Negoro S. PMID: 28280972.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    101. Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer. Int J Clin Oncol. 2017 02; 22(1):79. Yamamoto N, Goto K, Nishio M, Chikamori K, Hida T, Maemondo M, Katakami N, Kozuki T, Yoshioka H, Seto T, Tajima K, Tamura T. PMID: 27747455; PMCID: PMC6828350.
      View in: PubMed   Mentions: 1     Fields:    
    102. Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment. Respir Investig. 2017 Mar; 55(2):184-187. Furuuchi K, Nishiyama A, Yoshioka H, Yokoyama T, Ishida T. PMID: 28274537.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001. Int J Clin Oncol. 2017 Apr; 22(2):274-282. Okumura N, Sonobe M, Okabe K, Nakamura H, Kataoka M, Yamashita M, Nakata M, Kataoka K, Yamashita Y, Soh J, Yoshioka H, Hotta K, Matsuo K, Sakamoto J, Toyooka S, Date H. PMID: 27921177.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    104. Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 01; 18(1):100-103. Yoneshima Y, Morita S, Ando M, Miura S, Yoshioka H, Abe T, Kato T, Kondo M, Hosomi Y, Hotta K, Yamamoto N, Kishimoto J, Nakanishi Y, Okamoto I. PMID: 28341108.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    105. Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer. Int J Clin Oncol. 2017 Feb; 22(1):70-78. Yamamoto N, Goto K, Nishio M, Chikamori K, Hida T, Maemondo M, Katakami N, Kozuki T, Yoshioka H, Seto T, Tajima K, Tamura T. PMID: 27659294; PMCID: PMC5306267.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    106. Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience. Cancer Chemother Pharmacol. 2016 Nov; 78(5):941-947. Oda N, Hotta K, Yoshioka H, Kudo K, Ichihara E, Kato Y, Ninomiya K, Minami D, Ninomiya T, Kubo T, Ohashi K, Sato A, Takigawa N, Tabata M, Tanimoto M, Kiura K. PMID: 27590708.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    107. High-Resolution 3T MR Imaging of the Triangular Fibrocartilage Complex. Magn Reson Med Sci. 2017 Jan 10; 16(1):3-15. von Borstel D, Wang M, Small K, Nozaki T, Yoshioka H. PMID: 27535592; PMCID: PMC5600038.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    108. Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib. ESMO Open. 2016; 1(4):e000063. Azuma K, Hirashima T, Yamamoto N, Okamoto I, Takahashi T, Nishio M, Hirata T, Kubota K, Kasahara K, Hida T, Yoshioka H, Nakanishi K, Akinaga S, Nishio K, Mitsudomi T, Nakagawa K. PMID: 27843623; PMCID: PMC5070235.
      View in: PubMed   Mentions: 17  
    109. Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study. Lung Cancer. 2016 11; 101:1-8. Nosaki K, Satouchi M, Kurata T, Yoshida T, Okamoto I, Katakami N, Imamura F, Tanaka K, Yamane Y, Yamamoto N, Kato T, Kiura K, Saka H, Yoshioka H, Watanabe K, Mizuno K, Seto T. PMID: 27794396.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCTClinical Trials
    110. Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405). Clin Lung Cancer. 2016 11; 17(6):602-605. Isozaki H, Hotta K, Ichihara E, Takigawa N, Ohashi K, Kubo T, Ninomiya T, Ninomiya K, Oda N, Yoshioka H, Ichikawa H, Inoue M, Takata I, Shibayama T, Kuyama S, Sugimoto K, Harada D, Harita S, Sendo T, Tanimoto M, Kiura K. PMID: 27405684.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    111. Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L. J Clin Oncol. 2016 09 20; 34(27):3248-57. Urata Y, Katakami N, Morita S, Kaji R, Yoshioka H, Seto T, Satouchi M, Iwamoto Y, Kanehara M, Fujimoto D, Ikeda N, Murakami H, Daga H, Oguri T, Goto I, Imamura F, Sugawara S, Saka H, Nogami N, Negoro S, Nakagawa K, Nakanishi Y. PMID: 27022112.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCTClinical Trials
    112. Predicting Retear after Repair of Full-Thickness Rotator Cuff Tear: Two-Point Dixon MR Imaging Quantification of Fatty Muscle Degeneration-Initial Experience with 1-year Follow-up. Radiology. 2016 08; 280(2):500-9. Nozaki T, Tasaki A, Horiuchi S, Ochi J, Starkey J, Hara T, Saida Y, Yoshioka H. PMID: 26937710.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    113. Initial experience with 3D isotropic high-resolution 3 T MR arthrography of the wrist. BMC Musculoskelet Disord. 2016 Jan 16; 17:30. Sutherland JK, Nozaki T, Kaneko Y, J Yu H, Rafijah G, Hitt D, Yoshioka H. PMID: 26772813; PMCID: PMC4715345.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    114. Acceleration of skeletal age MR examination using compressed sensing. J Magn Reson Imaging. 2016 07; 44(1):204-11. Terada Y, Tamada D, Kose K, Nozaki T, Kaneko Y, Miyagi R, Yoshioka H. PMID: 26713540.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. Retroperitoneal Metastasis from Lung Adenocarcinoma Mimics Retroperitoneal Fibrosis. J Thorac Oncol. 2016 Feb; 11(2):266-7. Nishiyama A, Yoshioka H, Ikeo S, Morita M, Sone N, Ikeda S, Yokoyama T, Ishida T. PMID: 26718879.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    116. Composite Physiologic Index, Percent Forced Vital Capacity and Percent Diffusing Capacity for Carbon Monoxide Could Be Predictors of Pirfenidone Tolerability in Patients with Idiopathic Pulmonary Fibrosis. Intern Med. 2015; 54(22):2835-41. Konishi S, Arita M, Ito I, Tachibana H, Takaiwa T, Fukuda Y, Watanabe N, Tsubouchi K, Masuda G, Tanaka M, Kourogi Y, Kunimasa K, Nishiyama A, Iwasaku M, Ito A, Tokioka F, Yoshioka H, Hashimoto T, Ishida T. PMID: 26567995.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    117. Assessment of female ballet dancers' ankles in the en pointe position using high field strength magnetic resonance imaging. Acta Radiol. 2016 Aug; 57(8):978-84. Russell JA, Yoshioka H. PMID: 26567962.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    118. Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non-Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI. J Thorac Oncol. 2015 Nov; 10(11):1553-9. Hata A, Katakami N, Yoshioka H, Kaji R, Masago K, Fujita S, Imai Y, Nishiyama A, Ishida T, Nishimura Y, Yatabe Y. PMID: 26309190.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    119. T1rho mapping of entire femoral cartilage using depth- and angle-dependent analysis. Eur Radiol. 2016 Jun; 26(6):1952-62. Nozaki T, Kaneko Y, Yu HJ, Kaneshiro K, Schwarzkopf R, Hara T, Yoshioka H. PMID: 26396106; PMCID: PMC4803634.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    120. Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study. J Thorac Oncol. 2015 Sep; 10(9):1319-1327. Vansteenkiste JF, Canon JL, De Braud F, Grossi F, De Pas T, Gray JE, Su WC, Felip E, Yoshioka H, Gridelli C, Dy GK, Thongprasert S, Reck M, Aimone P, Vidam GA, Roussou P, Wang YA, Di Tomaso E, Soria JC. PMID: 26098748; PMCID: PMC4646607.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCTClinical Trials
    121. Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer. Clin Cancer Res. 2015 Dec 01; 21(23):5245-52. Iwamoto Y, Mitsudomi T, Sakai K, Yamanaka T, Yoshioka H, Takahama M, Yoshimura M, Yoshino I, Takeda M, Sugawara S, Kawaguchi T, Takahashi T, Ohta M, Ichinose Y, Atagi S, Okada M, Saka H, Nakagawa K, Nakanishi Y, Nishio K. PMID: 26253869.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    122. MR Imaging of the Triangular Fibrocartilage Complex. Magn Reson Imaging Clin N Am. 2015 Aug; 23(3):393-403. Cody ME, Nakamura DT, Small KM, Yoshioka H. PMID: 26216770.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    123. Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3. Cancer Sci. 2015 Sep; 106(9):1202-11. Kato T, Yoshioka H, Okamoto I, Yokoyama A, Hida T, Seto T, Kiura K, Massey D, Seki Y, Yamamoto N. PMID: 26094656; PMCID: PMC4582990.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    124. Quantification of Fatty Degeneration Within the Supraspinatus Muscle by Using a 2-Point Dixon Method on 3-T MRI. AJR Am J Roentgenol. 2015 Jul; 205(1):116-22. Nozaki T, Tasaki A, Horiuchi S, Osakabe C, Ohde S, Saida Y, Yoshioka H. PMID: 26102389.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    125. Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia. Intern Med. 2015; 54(13):1639-41. Furuta K, Ikeo S, Takaiwa T, Ikeda S, Nishiyama A, Yokoyama T, Ito A, Tokioka F, Tanaka M, Yoshioka H, Tachibana H, Arita M, Hashimoto T, Ishida T. PMID: 26134197.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    126. Consecutive assessment of FA and ADC values of normal lumbar nerve roots from the junction of the dura mater. BMC Musculoskelet Disord. 2015 Jun 27; 16:156. Miyagi R, Sakai T, Yamabe E, Yoshioka H. PMID: 26116552; PMCID: PMC4483211.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    127. Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer. Lung Cancer. 2015 Sep; 89(3):301-5. Nishiyama A, Katakami N, Yoshioka H, Iwasaku M, Korogi Y, Hata A, Takeshita J, Otsuka K, Nishino K, Uchida J, Okuyama T, Namba Y, Mori M, Fujita S, Morita S. PMID: 26141215.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    128. MRI findings of the shoulder and hip joint in patients with polymyalgia rheumatica. Mod Rheumatol. 2015 Sep; 25(5):761-7. Ochi J, Nozaki T, Okada M, Suyama Y, Kishimoto M, Akaike G, Tasaki A, Ohde S, Saida Y, Yoshioka H. PMID: 25698371.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    129. Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703. Cancer Chemother Pharmacol. 2015 Aug; 76(2):251-6. Kudo K, Hotta K, Ichihara E, Yoshioka H, Kunimasa K, Tsubouchi K, Iwasaku M, Kato Y, Oze I, Takigawa N, Tanimoto M, Kiura K. PMID: 26037206.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    130. Radiology of Fractures in Intoxicated Emergency Department Patients: Locations, Mechanisms, Presentation, and Initial Interpretation Accuracy. Medicine (Baltimore). 2015 Jun; 94(24):e980. Morita Y, Nozaki T, Starkey J, Okajima Y, Ohde S, Matsusako M, Yoshioka H, Saida Y, Kurihara Y. PMID: 26091471; PMCID: PMC4616526.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    131. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus. 2015; 4:240. Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, Ito A, Furuta K, Yokoyama T, Tokioka F, Noyama M, Yoshioka H, Ishida T. PMID: 26101728; PMCID: PMC4474966.
      View in: PubMed   Mentions: 15  
    132. Approach to MR Imaging of the Elbow and Wrist: Technical Aspects and Innovation. Magn Reson Imaging Clin N Am. 2015 Aug; 23(3):355-66. Johnson D, Stevens KJ, Riley G, Shapiro L, Yoshioka H, Gold GE. PMID: 26216768; PMCID: PMC4518502.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    133. Clinical characteristics of pneumonia in bedridden patients receiving home care: a 3-year prospective observational study. J Infect Chemother. 2015 Aug; 21(8):587-91. Ishida T, Tachibana H, Ito A, Ikeda S, Furuta K, Nishiyama A, Noyama M, Tokioka F, Yoshioka H, Arita M. PMID: 26026661.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    134. Normal T2 map profile of the entire femoral cartilage using an angle/layer-dependent approach. J Magn Reson Imaging. 2015 Dec; 42(6):1507-16. Kaneko Y, Nozaki T, Yu H, Chang A, Kaneshiro K, Schwarzkopf R, Hara T, Yoshioka H. PMID: 25917977; PMCID: PMC4624620.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    135. Comparison of T1rho imaging between spoiled gradient echo (SPGR) and balanced steady state free precession (b-FFE) sequence of knee cartilage at 3T MRI. Eur J Radiol. 2015 Jul; 84(7):1299-305. Nozaki T, Kaneko Y, Yu HJ, Kaneshiro K, Schwarzkopf R, Yoshioka H. PMID: 25956494; PMCID: PMC4712684.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    136. Patient-specific implants for lateral unicompartmental knee arthroplasty. Int Orthop. 2015 Aug; 39(8):1519-26. Demange MK, Von Keudell A, Probst C, Yoshioka H, Gomoll AH. PMID: 25645437.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    137. Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases. Anticancer Res. 2015 Feb; 35(2):1025-31. Hata A, Katakami N, Yoshioka H, Takeshita J, Tanaka K, Masago K, Fujita S, Kaji R, Imai Y, Monden K, Matsumoto T, Nagata K, Otsuka K, Tachikawa R, Tomii K, Kunimasa K, Iwasaku M, Nishiyama A, Ishida T, Nishimura Y. PMID: 25667490.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    138. Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803/WJOG4307L. J Clin Oncol. 2015 Feb 20; 33(6):575-81. Abe T, Takeda K, Ohe Y, Kudoh S, Ichinose Y, Okamoto H, Yamamoto N, Yoshioka H, Minato K, Sawa T, Iwamoto Y, Saka H, Mizusawa J, Shibata T, Nakamura S, Ando M, Yokoyama A, Nakagawa K, Saijo N, Tamura T. PMID: 25584004.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    139. Interstitial lung disease induced by alectinib (CH5424802/RO5424802). Jpn J Clin Oncol. 2015 Feb; 45(2):221-4. Ikeda S, Yoshioka H, Arita M, Sakai T, Sone N, Nishiyama A, Niwa T, Hotta M, Tanaka T, Ishida T. PMID: 25398579.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    140. Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancer. Lung Cancer. 2014 Nov; 86(2):201-6. Yoshioka H, Komuta K, Imamura F, Kudoh S, Seki A, Fukuoka M. PMID: 25280386.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    141. Improved reliability in skeletal age assessment using a pediatric hand MR scanner with a 0.3T permanent magnet. Magn Reson Med Sci. 2014; 13(3):215-9. Terada Y, Kono S, Uchiumi T, Kose K, Miyagi R, Yamabe E, Fujinaga Y, Yoshioka H. PMID: 24990466.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    142. Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study. Oncotarget. 2014 Apr 30; 5(8):2293-304. Okamoto I, Sakai K, Morita S, Yoshioka H, Kaneda H, Takeda K, Hirashima T, Kogure Y, Kimura T, Takahashi T, Atagi S, Seto T, Sawa T, Yamamoto M, Satouchi M, Okuno M, Nagase S, Takayama K, Tomii K, Maeda T, Oizumi S, Fujii S, Akashi Y, Nishino K, Ebi N, Nakagawa K, Nakanishi Y, Nishio K. PMID: 24810493; PMCID: PMC4039163.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    143. How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations? J Thorac Oncol. 2014 Feb; 9(2):e20. Hata A, Katakami N, Yoshioka H. PMID: 24419432.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    144. Diffusion-weighted imaging and diffusion tensor imaging of asymptomatic lumbar disc herniation. J Med Invest. 2014; 61(1-2):197-203. Sakai T, Miyagi R, Yamabe E, Fujinaga Y, N Bhatia N, Yoshioka H. PMID: 24705766.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    145. Comparison between high-resolution isotropic three-dimensional and high-resolution conventional two-dimensional FSE MR images of the wrist at 3 tesla: a pilot study. J Magn Reson Imaging. 2014 Sep; 40(3):603-8. Yamabe E, Anavim A, Sakai T, Miyagi R, Nakamura T, Hitt D, Yoshioka H. PMID: 24227687.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    146. Quantitative measurement of femoral condyle cartilage in the knee by MRI: validation study by multireaders. J Magn Reson Imaging. 2014 Apr; 39(4):972-7. Fujinaga Y, Yoshioka H, Sakai T, Sakai Y, Souza F, Lang P. PMID: 24123712; PMCID: PMC3962518.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    147. Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer. Anticancer Res. 2013 Oct; 33(10):4631-7. Kawahara M, Atagi S, Komuta K, Yoshioka H, Kawasaki M, Fujita Y, Yonei T, Ogushi F, Kubota K, Nogami N, Tsuchiya M, Shibata K, Tomizawa Y, Minato K, Fukuoka K, Asami K, Yamanaka T, Japan Multinational Trial Organization. PMID: 24123041.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    148. Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations. Cancer. 2013 Dec 15; 119(24):4325-32. Hata A, Katakami N, Yoshioka H, Takeshita J, Tanaka K, Nanjo S, Fujita S, Kaji R, Imai Y, Monden K, Matsumoto T, Nagata K, Otsuka K, Tachikawa R, Tomii K, Kunimasa K, Iwasaku M, Nishiyama A, Ishida T, Nishimura Y. PMID: 24105277.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    149. A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC). Lung Cancer. 2013 Oct; 82(1):109-14. Goto K, Nishio M, Yamamoto N, Chikamori K, Hida T, Maemondo M, Katakami N, Kozuki T, Yoshioka H, Seto T, Fukuyama T, Tamura T. PMID: 23910906.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    150. Study of surgical indication for knee arthroplasty by cartilage analysis in three compartments using data from Osteoarthritis Initiative (OAI). BMC Musculoskelet Disord. 2013 Jun 25; 14:194. Yamabe E, Ueno T, Miyagi R, Watanabe A, Guenzi C, Yoshioka H. PMID: 23800392; PMCID: PMC3695763.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    151. [A case of lung disease and spondylitis due to Mycobacterium intracellulare in a immunocompetent patient]. Kekkaku. 2013 Jun; 88(6):559-64. Ito A, Hashimoto T, Ishida T, Tachibana H, Korogi Y, Tokioka F, Yoshioka H. PMID: 23898496.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    152. CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study. Lancet Oncol. 2013 Jun; 14(7):590-8. Seto T, Kiura K, Nishio M, Nakagawa K, Maemondo M, Inoue A, Hida T, Yamamoto N, Yoshioka H, Harada M, Ohe Y, Nogami N, Takeuchi K, Shimada T, Tanaka T, Tamura T. PMID: 23639470.
      View in: PubMed   Mentions: 251     Fields:    Translation:HumansCTClinical Trials
    153. Nested case control study of proteomic biomarkers for interstitial lung disease in Japanese patients with non-small-cell lung cancer treated with erlotinib: a multicenter phase IV study (JO21661). Clin Lung Cancer. 2013 Jul; 14(4):407-17. Atagi S, Katakami N, Yoshioka H, Fukuoka M, Kudoh S, Ogiwara A, Imai M, Ueda M, Matsui S. PMID: 23490546.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    154. How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations? J Thorac Oncol. 2013 Jan; 8(1):89-95. Hata A, Katakami N, Yoshioka H, Kunimasa K, Fujita S, Kaji R, Notohara K, Imai Y, Tachikawa R, Tomii K, Korogi Y, Iwasaku M, Nishiyama A, Ishida T. PMID: 23242440.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    155. The athlete's wrist: ulnar-sided pain. Semin Musculoskelet Radiol. 2012 Sep; 16(4):331-7. Yamabe E, Nakamura T, Pham P, Yoshioka H. PMID: 23047280.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    156. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med. 2012; 51(18):2537-44. Ishida T, Tachibana H, Ito A, Yoshioka H, Arita M, Hashimoto T. PMID: 22989823.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    157. Skeletal age assessment in children using an open compact MRI system. Magn Reson Med. 2013 Jun; 69(6):1697-702. Terada Y, Kono S, Tamada D, Uchiumi T, Kose K, Miyagi R, Yamabe E, Yoshioka H. PMID: 22851444.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    158. Two types of laminolysis in adolescent athletes. J Orthop Traumatol. 2012 Dec; 13(4):225-8. Miyagi R, Sairyo K, Sakai T, Yoshioka H, Yasui N, Dezawa A. PMID: 22815057; PMCID: PMC3506832.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    159. Effect of green tea extract on reactive oxygen species produced by neutrophils from cancer patients. Anticancer Res. 2012 Jun; 32(6):2369-75. Suzuki K, Ohno S, Suzuki Y, Ohno Y, Okuyama R, Aruga A, Yamamoto M, Ishihara KO, Nozaki T, Miura S, Yoshioka H, Mori Y. PMID: 22641677.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    160. Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial. BMC Cancer. 2012 May 21; 12:185. Fujita S, Katakami N, Masago K, Yoshioka H, Tomii K, Kaneda T, Hirabayashi M, Kunimasa K, Morizane T, Mio T. PMID: 22613958; PMCID: PMC3404930.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    161. Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group. Lung Cancer. 2012 Jul; 77(1):134-9. Umemura S, Tsubouchi K, Yoshioka H, Hotta K, Takigawa N, Fujiwara K, Horita N, Segawa Y, Hamada N, Takata I, Yamane H, Kamei H, Kiura K, Tanimoto M. PMID: 22487432.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    162. Magnetic resonance imaging of triangular fibrocartilage. J Magn Reson Imaging. 2012 Apr; 35(4):764-78. Yoshioka H, Burns JE. PMID: 22434698.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    163. A weekly combination of carboplatin and irinotecan for previously untreated extensive disease small-cell lung cancer, results of a minimum follow-up of 3 years: a multi-center Phase II trial JMTO LC02-02. Jpn J Clin Oncol. 2012 May; 42(5):387-93. Okishio K, Mio T, Kawahara M, Yoshioka H, Yanagihara K, Daimon T, Furuse K. PMID: 22430871.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    164. Successful treatment of non-small cell lung cancer with gefitinib after severe erlotinib-related hepatotoxicity. Intern Med. 2012; 51(4):431-4. Kunimasa K, Yoshioka H, Iwasaku M, Nishiyama A, Korogi Y, Masuda G, Takaiwa T, Ishida T. PMID: 22333382.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    165. Determination of chronic inflammatory states in cancer patients using assay of reactive oxygen species production by neutrophils. Anticancer Res. 2012 Feb; 32(2):565-70. Suzuki Y, Ohno S, Okuyama R, Aruga A, Yamamoto M, Miura S, Yoshioka H, Mori Y, Suzuki K. PMID: 22287746.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    166. Phase I clinical study of the angiogenesis inhibitor TSU-68 combined with carboplatin and paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancer. J Thorac Oncol. 2012 Feb; 7(2):427-33. Okamoto I, Yoshioka H, Takeda K, Satouchi M, Yamamoto N, Seto T, Kasahara K, Miyazaki M, Kitamura R, Ohyama A, Hokoda N, Nakayama H, Yoshihara E, Nakagawa K. PMID: 22071785.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    167. Pneumatosis cystoides intestinalis after gefitinib therapy for pulmonary adenocarcinoma. J Thorac Oncol. 2012 Jan; 7(1):257. Iwasaku M, Yoshioka H, Korogi Y, Kunimasa K, Nishiyama A, Nagai H, Ishida T. PMID: 22173663.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    168. Erlotinib for pretreated squamous cell carcinoma of the lung in Japanese patients. Jpn J Clin Oncol. 2011 Dec; 41(12):1366-72. Hata A, Katakami N, Kunimasa K, Yoshioka H, Fujita S, Kaji R, Tachikawa R, Tomii K, Imai Y, Iwasaku M, Ishida T. PMID: 22058419.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    169. Preoperative Measurement of Cartilage Defects by MRI Underestimates Lesion Size. Cartilage. 2011 Oct; 2(4):389-93. Gomoll AH, Yoshioka H, Watanabe A, Dunn JC, Minas T. PMID: 26069597; PMCID: PMC4297136.
      View in: PubMed   Mentions: 24     Fields:    
    170. Validation of scoring systems for predicting severe community-acquired pneumonia. Intern Med. 2011; 50(18):1917-22. Fukuyama H, Ishida T, Tachibana H, Nakagawa H, Iwasaku M, Saigusa M, Yoshioka H, Arita M, Hashimoto T. PMID: 21921369.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    171. Phase II study of gefitinib as a first-line therapy in elderly patients with pulmonary adenocarcinoma: West Japan Thoracic Oncology Group Study 0402. Jpn J Clin Oncol. 2011 Aug; 41(8):948-52. Kobayashi M, Matsui K, Katakami N, Takeda K, Moriyama A, Iwamoto Y, Takada M, Yoshioka H, Sueoka-Aragane N, Nakagawa K, West Japan Oncology Group. PMID: 21715363.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    172. Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selection. Lung Cancer. 2011 Nov; 74(2):268-73. Hata A, Katakami N, Yoshioka H, Fujita S, Kunimasa K, Nanjo S, Otsuka K, Kaji R, Tomii K, Iwasaku M, Nishiyama A, Hayashi H, Morita S, Ishida T. PMID: 21529987.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    173. Pitfalls that may mimic injuries of the triangular fibrocartilage and proximal intrinsic wrist ligaments at MR imaging. Radiographics. 2011 Jan-Feb; 31(1):63-78. Burns JE, Tanaka T, Ueno T, Nakamura T, Yoshioka H. PMID: 21257933.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    174. [Clinical evaluation of bedridden patients with pneumonia receiving home health care]. Nihon Kokyuki Gakkai Zasshi. 2010 Dec; 48(12):906-11. Fukuyama H, Ishida T, Tachibana H, Iga C, Nakagawa H, Ito A, Ubukata S, Yoshioka H, Arita M, Hashimoto T. PMID: 21226296.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    175. Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study. J Clin Oncol. 2010 Dec 20; 28(36):5240-6. Okamoto I, Yoshioka H, Morita S, Ando M, Takeda K, Seto T, Yamamoto N, Saka H, Asami K, Hirashima T, Kudoh S, Satouchi M, Ikeda N, Iwamoto Y, Sawa T, Miyazaki M, Tamura K, Kurata T, Fukuoka M, Nakagawa K. PMID: 21079147.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    176. Desire for information and involvement in treatment decisions: lung cancer patients' preferences and their physicians' perceptions: results from Okayama Lung Cancer Study Group Trial 0705. J Thorac Oncol. 2010 Oct; 5(10):1668-72. Hotta K, Kiura K, Takigawa N, Yoshioka H, Hayashi H, Fukuyama H, Nishiyama A, Yokoyama T, Kuyama S, Umemura S, Kato Y, Nogami N, Segawa Y, Yasugi M, Tabata M, Tanimoto M. PMID: 20871267.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    177. Complex mutations in the epidermal growth factor receptor gene in non-small cell lung cancer. J Thorac Oncol. 2010 Oct; 5(10):1524-8. Hata A, Yoshioka H, Fujita S, Kunimasa K, Kaji R, Imai Y, Tomii K, Iwasaku M, Nishiyama A, Ishida T, Katakami N. PMID: 20808254.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    178. A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503. J Thorac Oncol. 2010 Sep; 5(9):1430-4. Segawa Y, Kiura K, Hotta K, Takigawa N, Tabata M, Matsuo K, Yoshioka H, Hayashi H, Kawai H, Aoe K, Maeda T, Ueoka H, Tanimoto M. PMID: 20651615.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    179. Magnetic resonance imaging of the ankle in female ballet dancers en pointe. Acta Radiol. 2010 Jul; 51(6):655-61. Russell JA, Shave RM, Yoshioka H, Kruse DW, Koutedakis Y, Wyon MA. PMID: 20482223.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    180. Pleural metastases of malignant melanoma. J Thorac Oncol. 2010 Jun; 5(6):908. Nishiyama A, Yoshioka H, Ishida T. PMID: 20502270.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    181. Definition of ulnomeniscal homologue of the wrist. Radiology. 2010 May; 255(2):661; author reply 661-2. Yoshioka H. PMID: 20413778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    182. Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experience. Lung Cancer. 2010 Dec; 70(3):308-12. Hotta K, Kiura K, Takigawa N, Suzuki E, Yoshioka H, Okada T, Kishino D, Ueoka H, Inoue K, Tabata M, Tanimoto M. PMID: 20416970.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    183. Localized malignant pleural mesothelioma showing a thoracic mass and metastasizing to the stomach. Intern Med. 2010; 49(7):671-5. Hayashi H, Notohara K, Yoshioka H, Matsuoka T, Ikeda H, Kagawa K, Fukuoka T, Ishida T. PMID: 20371957.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    184. Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed. Int J Clin Oncol. 2010 Oct; 15(5):497-9. Hayashi H, Okamoto I, Ichikawa Y, Miyazaki M, Yoshioka H, Kunimasa K, Nakagawa K. PMID: 20224880.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    185. Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience. J Thorac Oncol. 2010 Feb; 5(2):179-84. Hotta K, Kiura K, Takigawa N, Yoshioka H, Harita S, Kuyama S, Yonei T, Fujiwara K, Maeda T, Aoe K, Ueoka H, Kamei H, Umemura S, Moritaka T, Segawa Y, Kawai H, Bessho A, Kato K, Tabata M, Tanimoto M. PMID: 20101144.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    186. [Two cases of non-small cell lung cancer which developed central nervous system metastases during gefitinib treatment, improving after changing to erlotinib treatment]. Nihon Kokyuki Gakkai Zasshi. 2010 Feb; 48(2):166-71. Kunimasa K, Yoshioka H, Iwasaku M, Nishiyama A, Ubukata S, Ishida T. PMID: 20184251.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    187. Magnetic resonance imaging of articular cartilage abnormalities of the far posterior femoral condyle of the knee. Acta Radiol. 2010 Feb; 51(1):52-7. Ogino S, Huang T, Watanabe A, Iranpour-Boroujeni T, Yoshioka H. PMID: 19912077.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    188. A phase II trial of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active EGFR mutations: Okayama Lung Cancer Study Group trial 0705. J Thorac Oncol. 2010 Jan; 5(1):99-104. Yoshioka H, Hotta K, Kiura K, Takigawa N, Hayashi H, Harita S, Kuyama S, Segawa Y, Kamei H, Umemura S, Bessho A, Tabata M, Tanimoto M, Okayama Lung Cancer Study Group. PMID: 19898258.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    189. Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG0401). J Thorac Oncol. 2010 Jan; 5(1):105-9. Kaneda H, Okamoto I, Hayashi H, Yoshioka H, Miyazaki M, Kudoh S, Kimura T, Sugiura T, Sawa T, Takeda K, Iwamoto Y, Satouchi M, Akita K, Saito H, Goto I, Shibata K, Fukuoka M, Nakagawa K, West Japan Thoracic Oncology Group. PMID: 19884859.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    190. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 2010 Feb; 11(2):121-8. Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M, West Japan Oncology Group. PMID: 20022809.
      View in: PubMed   Mentions: 1856     Fields:    Translation:HumansCTClinical Trials
    191. Ulnar-sided wrist pain. II. Clinical imaging and treatment. Skeletal Radiol. 2010 Sep; 39(9):837-57. Watanabe A, Souza F, Vezeridis PS, Blazar P, Yoshioka H. PMID: 20012039; PMCID: PMC2904904.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    192. Empirical evaluation of the inter-relationship of articular elements involved in the pathoanatomy of knee osteoarthritis using magnetic resonance imaging. BMC Musculoskelet Disord. 2009 Oct 29; 10:133. Meredith DS, Losina E, Neumann G, Yoshioka H, Lang PK, Katz JN. PMID: 19874594; PMCID: PMC2774678.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    193. Ulnar-sided wrist pain. Part I: anatomy and physical examination. Skeletal Radiol. 2010 Aug; 39(8):733-45. Vezeridis PS, Yoshioka H, Han R, Blazar P. PMID: 19722104; PMCID: PMC2895881.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    194. Ligamentous injuries of the wrist. Semin Musculoskelet Radiol. 2008 Dec; 12(4):359-77. Tanaka T, Ogino S, Yoshioka H. PMID: 19016398.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    195. Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505. Clin Cancer Res. 2008 Aug 15; 14(16):5250-4. Okamoto I, Nishimura T, Miyazaki M, Yoshioka H, Kubo A, Takeda K, Ebi N, Sugawara S, Katakami N, Fukuoka M, Nakagawa K. PMID: 18698044.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    196. [Drug-induced pulmonary damage due to inhalation of a waterproof spray]. Nihon Kokyuki Gakkai Zasshi. 2008 Jan; 46(1):35-8. Hayashi H, Ishii T, Ishida T, Saigusa M, Fukuyama H, Yamamoto M, Yokoyama T, Tokioka H, Nagai H, Noyama M, Yoshioka H, Tachibana H, Arita M, Hashimoto T. PMID: 18260308.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    197. Prone positioning improves distribution of pulmonary perfusion: noninvasive magnetic resonance imaging study in healthy humans. Eur Radiol. 2008 Mar; 18(3):522-8. Suzuki H, Sato Y, Shindo M, Yoshioka H, Mizutani T, Onizuka M, Sakakibara Y. PMID: 18071711.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    198. High-resolution MRI of the triangular fibrocartilage complex (TFCC) at 3T: comparison of surface coil and volume coil. J Magn Reson Imaging. 2007 Sep; 26(3):701-7. Bittersohl B, Huang T, Schneider E, Blazar P, Winalski C, Lang P, Yoshioka H. PMID: 17729361.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    199. Study of ulnar variance with high-resolution MRI: correlation with triangular fibrocartilage complex and cartilage of ulnar side of wrist. J Magn Reson Imaging. 2007 Sep; 26(3):714-9. Yoshioka H, Tanaka T, Ueno T, Carrino JA, Winalski CS, Aliabadi P, Lang P, Weissman BN. PMID: 17729368.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    200. Comparison between high-resolution MRI with a microscopy coil and arthroscopy in triangular fibrocartilage complex injury. J Hand Surg Am. 2006 Oct; 31(8):1308-14. Tanaka T, Yoshioka H, Ueno T, Shindo M, Ochiai N. PMID: 17027792.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    201. High-resolution MR imaging of the proximal zone of the lunotriquetral ligament with a microscopy coil. Skeletal Radiol. 2006 May; 35(5):288-94. Yoshioka H, Tanaka T, Ueno T, Shindo M, Carrino JA, Lang P, Winalski CS. PMID: 16534640.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    202. Low-field compact magnetic resonance imaging system for the hand and wrist in rheumatoid arthritis. J Magn Reson Imaging. 2006 Mar; 23(3):370-6. Yoshioka H, Ito S, Handa S, Tomiha S, Kose K, Haishi T, Tsutsumi A, Sumida T. PMID: 16456819.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    203. MR imaging of articular cartilage: current state and recent developments. Radiol Clin North Am. 2005 Jul; 43(4):629-39, vii. Lang P, Noorbakhsh F, Yoshioka H. PMID: 15893527.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    204. Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: comparison of the diagnostic accuracy among the early, middle, late, and whole triple arterial phase imaging. AJR Am J Roentgenol. 2005 Jan; 184(1):63-9. Mori K, Yoshioka H, Takahashi N, Yamaguchi M, Ueno T, Yamaki T, Saida Y. PMID: 15615952.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    205. Magnetic resonance imaging of articular cartilage of the knee: comparison between fat-suppressed three-dimensional SPGR imaging, fat-suppressed FSE imaging, and fat-suppressed three-dimensional DEFT imaging, and correlation with arthroscopy. J Magn Reson Imaging. 2004 Nov; 20(5):857-64. Yoshioka H, Stevens K, Hargreaves BA, Steines D, Genovese M, Dillingham MF, Winalski CS, Lang P. PMID: 15503323.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    206. Bone scintigraphic and CT evaluation of chondrosarcoma of the rib: correlation with histological grade in 6 cases. Ann Nucl Med. 2004 Oct; 18(7):633-6. Ehara S, Nakayama T, Nishida J, Shiraishi H, Yoshioka H, Aoki J. PMID: 15586640.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    207. Three-dimensional fast field echo MR myelography using water excitation. Comput Med Imaging Graph. 2004 Sep; 28(6):363-9. Takahashi N, Niitsu M, Yoshioka H, Saida Y. PMID: 15294314.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    208. Gene expression profile of human mesenchymal stem cells during osteogenesis in three-dimensional thermoreversible gelation polymer. Biochem Biophys Res Commun. 2004 May 14; 317(4):1103-7. Hishikawa K, Miura S, Marumo T, Yoshioka H, Mori Y, Takato T, Fujita T. PMID: 15094382.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    209. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging? Magn Reson Imaging. 2004 Apr; 22(3):361-7. Yoshioka H, Sato J, Takahashi N, Lou D, Yamaguchi M, Saida Y, Itai Y. PMID: 15062931.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    210. Articular cartilage of knee: normal patterns at MR imaging that mimic disease in healthy subjects and patients with osteoarthritis. Radiology. 2004 Apr; 231(1):31-8. Yoshioka H, Stevens K, Genovese M, Dillingham MF, Lang P. PMID: 15068938.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    211. High-resolution MR imaging of the elbow using a microscopy surface coil and a clinical 1.5 T MR machine: preliminary results. Skeletal Radiol. 2004 May; 33(5):265-71. Yoshioka H, Ueno T, Tanaka T, Kujiraoka Y, Shindo M, Takahashi N, Nishiura Y, Ochiai N, Saida Y. PMID: 15045469.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    212. MR findings of spinal muscular atrophy Type II: sibling cases. Magn Reson Med Sci. 2003 Dec 31; 2(4):195-8. Ueno T, Yoshioka H, Iwasaki N, Tanaka R, Saida Y. PMID: 16222114.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    213. MR imaging of epidermoids at the cerebellopontine angle. Magn Reson Med Sci. 2003 Oct 01; 2(3):109-15. Liu P, Saida Y, Yoshioka H, Itai Y. PMID: 16222102.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    214. High-resolution MR imaging of triangular fibrocartilage complex (TFCC): comparison of microscopy coils and a conventional small surface coil. Skeletal Radiol. 2003 Oct; 32(10):575-81. Yoshioka H, Ueno T, Tanaka T, Shindo M, Itai Y. PMID: 12942205.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    215. Accelerated dynamic MR imaging with a parallel imaging technique for hypervascular hepatocellular carcinomas: usefulness of a test bolus in examination and subtraction imaging. J Magn Reson Imaging. 2003 Jul; 18(1):80-9. Takahashi N, Yoshioka H, Yamaguchi M, Saida Y, Itai Y. PMID: 12815643.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    216. Imaging of the articular cartilage in osteoarthritis of the knee joint: 3D spatial-spectral spoiled gradient-echo vs. fat-suppressed 3D spoiled gradient-echo MR imaging. J Magn Reson Imaging. 2003 Jul; 18(1):66-71. Yoshioka H, Alley M, Steines D, Stevens K, Rubesova E, Genovese M, Dillingham MF, Lang P. PMID: 12815641.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    217. The use of magnetic resonance imaging to evaluate the effects of cooling on skeletal muscle after strenuous exercise. Eur J Appl Physiol. 2003 Mar; 89(1):53-62. Yanagisawa O, Niitsu M, Yoshioka H, Goto K, Kudo H, Itai Y. PMID: 12627305.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    218. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas. J Magn Reson Imaging. 2002 Sep; 16(3):259-66. Yoshioka H, Takahashi N, Yamaguchi M, Lou D, Saida Y, Itai Y. PMID: 12205581.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    219. MR microscopy of articular cartilage at 1.5 T: orientation and site dependence of laminar structures. Skeletal Radiol. 2002 Sep; 31(9):505-10. Yoshioka H, Haishi T, Uematsu T, Matsuda Y, Anno I, Echigo J, Lang P, Itai Y, Kose K. PMID: 12195502.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    220. Radiation-induced liver injury showing low intensity on T2-weighted images noted in Budd-Chiari syndrome. Radiat Med. 2002 Mar-Apr; 20(2):69-76. Mori H, Yoshioka H, Mori K, Ahmadi T, Okumura T, Saida Y, Itai Y. PMID: 12041701.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    Hiroshi's Networks
    Concepts (514)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California